clinical trials

News

Delayed TNBC readout for Datroway delivers survival benefit

AstraZeneca and Daiichi Sankyo's Datroway comes good in the delayed TROPION-Breast02 trial as a frontline triple-negative breast cancer treatment.

R&D

Q3 Clinical trials round-up: July to September 2025

As the third quarter of 2025 draws to a close, the clinical research landscape has been marked by a surge of promising data and regulatory milestones.

Patients

Streamlining post-trial treatment access for rare disease pa...

Companies have a practical and ethical responsibility to continue treating patients when clinical trial data collection ends mid-trial.

News

Data backs Vertanical's cannabis therapy for back pain

A phase 3 trial of Vertanical's cannabis extract in back pain has been published, and the results bode well for marketing applications under review.

News

Enhertu scores again in early breast cancer

AstraZeneca and Daiichi Sankyo are eyeing regulatory filings for Enhertu in early breast cancer after a second phase 3 trial delivers.

News

Enanta weakens on RSV treatment trial readout

Shares in Enanta Pharma were sliding this morning after it reported results of a phase 2b trial of its RSV antiviral zelicapavir.

Delayed TNBC readout for Datroway delivers survival benefit

Q3 Clinical trials round-up: July to September 2025

Streamlining post-trial treatment access for rare disease pa...

Data backs Vertanical's cannabis therapy for back pain

Enhertu scores again in early breast cancer

Enanta weakens on RSV treatment trial readout

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks